Evidence map›Paper›PMID 40887203›Full record

ReviewSheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi2025

[Research progress on the early warning of heart failure based on remote dynamic monitoring technology].

Ying Shi, Mengwei Li, Lixuan Li, Wei Yan, Desen Cao, Zhengbo Zhang, Muyang Yan

Abstract readReviewEnglish Abstract
In one paragraph

Review in Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ying ShiChinese PLA Medical School, Beijing 100853, P. R. China.
Mengwei LiCenter for Artificial Intelligence, Chinese PLA General Hospital, Beijing 100853, P. R. China.
Lixuan LiCenter for Artificial Intelligence, Chinese PLA General Hospital, Beijing 100853, P. R. China.
Wei YanDepartment of Hyperbaric Oxygen, the First Medical Center, Chinese PLA General Hospital, Beijing 100853, P. R. China.
Desen CaoDepartment of Medical Engineering, Medical Supplies Center, Chinese PLA General Hospital, Beijing 100853, P. R. China.
Zhengbo ZhangCenter for Artificial Intelligence, Chinese PLA General Hospital, Beijing 100853, P. R. China.
Muyang YanBeidaihe Rest and Recuperation Center of PLA, Qinhuangdao, Hebei 066000, P. R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Heart failure (HF) is the end-stage of all cardiac diseases, characterized by high prevalence, high mortality, and heavy social and economic burden. Early warning of HF exacerbation is of great value for outpatient management and reducing readmission rates. Currently, remote dynamic monitoring technology, which captures changes in hemodynamic and physiological parameters of HF patients, has become the primary method for early warning and is a hot research topic in clinical studies. This paper systematically reviews the progress in this field, which was categorized into invasive monitoring based on implanted devices, non-invasive monitoring based on wearable devices, and other monitoring technologies based on audio and video. Invasive monitoring primarily involves direct hemodynamic parameters such as left atrial pressure and pulmonary artery pressure, while non-invasive monitoring covers parameters such as thoracic impedance, electrocardiogram, respiration, and activity levels. These parameters exhibit characteristic changes in the early stages of HF exacerbation. Given the clinical heterogeneity of HF patients, multi-source information fusion analysis can significantly improve the prediction accuracy of early warning models. The results of this study suggest that, compared with invasive monitoring, non-invasive monitoring technology, with its advantages of good patient compliance, ease of operation, and cost-effectiveness, combined with AI-driven multimodal data analysis methods, shows significant clinical application potential in establishing an outpatient management system for HF.

Indexed as

Heart FailureRemote Sensing TechnologyEarly DiagnosisElectrocardiographyHemodynamicsHumansMonitoring, PhysiologicWearable Electronic DevicesDisease managementEarly warningHeart failureRemote dynamic monitoring

Identifiers

PMID40887203
PMCPMC12409507

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.